foxo4-dri human trial senolytic Development of a novel by precise disruption of FOXO4-p53 complex FOXO4-DRI Results: What to Expect

J Physiol Pharmacol 69(3) Lovric-Bencic M, Sikiric P, Hanzevacki JS, Seiwerth S, Rogic D, Kusec V et al (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC 157 in rat and mouse

These are the same mechanisms that traditional immunotherapy uses, but peptide immunotherapy appears to achieve them faster and with fewer risks

PubMed Kruse, T., Wendelboe, P., Kragelund, R.P., Pettersson, I., Kaae, S., Hansen, J.B., et al

Even with weekly injections for a full year, the cumulative weekly B6 dose from the compound alone ranges from 5 to 10 mg, far below the levels associated with neuropathy